Global Epigenetics Drugs & Diagnostic Technologies Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Epigenetic Drugs and Diagnostic Technologies), By Technology (DNA Methylation, Histone Modification, RNA Modification, and Others), By Application (Oncology and Non-Oncology), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Oct 2025
REPORT ID SI16223
PAGES 240
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Product Type
      2. Market Attractiveness Analysis By Technology
      3. Market Attractiveness Analysis By Application
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Growing prevalence of cancer, neurological, and autoimmune disease.
    3. Restraints
      1.  High R&D costs and complicated regulatory processes.
    4. Opportunities
      1.  Developing new epigenetic drugs and improving diagnostic tools.
    5. Challenges
      1. High costs and complexity of the science.

 

  1. Global Epigenetics Drugs & Diagnostic Technologies Market Analysis and Projection, By Product Type
    1. Segment Overview
    2. Epigenetic Drugs
    3. Diagnostic Technologies
  2. Global Epigenetics Drugs & Diagnostic Technologies Market Analysis and Projection, By Technology
    1. Segment Overview
    2. DNA Methylation
    3. Histone Modification
    4. RNA Modification
    5. Others
  3. Global Epigenetics Drugs & Diagnostic Technologies Market Analysis and Projection, By Application
    1. Segment Overview
    2. Oncology
    3. Non-Oncology
  4. Global Epigenetics Drugs & Diagnostic Technologies Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  5. Global Epigenetics Drugs & Diagnostic Technologies Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Epigenetics Drugs & Diagnostic Technologies Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  6. Company Profiles
    1. Thermo Fisher Scientific Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Eisai Co., Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Roche Diagnostics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Illumina, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Cantata Bio 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   ELEMENT BIOSCIENCES
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Active Motif Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Qiagen
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Agilent Technologies 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Merck KGaA
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Abcam Limited.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Hoffmann-La Roche Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Zymo Research Corporation
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  2. Global Epigenetic Drugs, Epigenetics Drugs & Diagnostic Technologies Market, By Region, 2024-2034(USD Billion)
  3. Global Diagnostic Technologies, Epigenetics Drugs & Diagnostic Technologies Market, By Region, 2024-2034(USD Billion)
  4. Global Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  5. Global DNA Methylation, Epigenetics Drugs & Diagnostic Technologies Market, By Region, 2024-2034(USD Billion)
  6. Global Histone Modification, Epigenetics Drugs & Diagnostic Technologies Market, By Region, 2024-2034(USD Billion)
  7. Global RNA Modification, Epigenetics Drugs & Diagnostic Technologies Market, By Region, 2024-2034(USD Billion)
  8. Global Others, Epigenetics Drugs & Diagnostic Technologies Market, By Region, 2024-2034(USD Billion)
  9. Global Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  10. Global Oncology, Epigenetics Drugs & Diagnostic Technologies Market, By Region, 2024-2034(USD Billion)
  11. Global Non-Oncology, Epigenetics Drugs & Diagnostic Technologies Market, By Region, 2024-2034(USD Billion)
  12. North America Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  13. North America Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  14. North America Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  15. U.S.  Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  16. U.S.  Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  17. U.S.  Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  18. Canada Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  19. Canada Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  20. Canada Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  21. Mexico Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  22. Mexico Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  23. Mexico Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  24. Europe Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  25. Europe Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  26. Europe Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  27. Germany Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  28. Germany Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  29. Germany Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  30. France Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  31. France Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  32. France Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  33. U.K.  Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  34. U.K.  Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  35. U.K.  Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  36. Italy Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  37. Italy Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  38. Italy Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  39. Spain Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  40. Spain Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  41. Spain Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  42. Asia Pacific Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  43. Asia Pacific Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  44. Asia Pacific Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  45. Japan Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  46. Japan Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  47. Japan Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  48. China Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  49. China Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  50. China Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  51. India Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  52. India Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  53. India Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  54. South America Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  55. South America Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  56. South America Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  57. Brazil Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  58. Brazil Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  59. Brazil Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  60. The Middle East and Africa Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD   Billion)
  61. The Middle East and Africa Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD   Billion)
  62. The Middle East and Africa Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  63. UAE Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  64. UAE Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  65. UAE Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)
  66. South Africa Epigenetics Drugs & Diagnostic Technologies Market, By Product Type, 2024-2034(USD Billion)
  67. South Africa Epigenetics Drugs & Diagnostic Technologies Market, By Technology, 2024-2034(USD Billion)
  68. South Africa Epigenetics Drugs & Diagnostic Technologies Market, By Application, 2024-2034(USD Billion)

 

List of Figures 

  1. Global Epigenetics Drugs & Diagnostic Technologies Market Segmentation
  2. Epigenetics Drugs & Diagnostic Technologies Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Epigenetics Drugs & Diagnostic Technologies Market
  9. Top Winning Strategies, 2024-2034
  10. Top Winning Strategies, By Development, 2024-2034(%)
  11. Top Winning Strategies, By Company, 2024-2034
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Epigenetics Drugs & Diagnostic Technologies Market
  20. Epigenetics Drugs & Diagnostic Technologies Market Segmentation, By Product Type
  21. Epigenetics Drugs & Diagnostic Technologies Market For Epigenetic Drugs, By Region, 2024-2034 ($ Billion)
  22.  Epigenetics Drugs & Diagnostic Technologies Market For Diagnostic Technologies, By Region, 2024-2034 ($ Billion)
  23.  Epigenetics Drugs & Diagnostic Technologies Market Segmentation, By Technology
  24.  Epigenetics Drugs & Diagnostic Technologies Market For DNA Methylation, By Region, 2024-2034 ($ Billion)
  25.  Epigenetics Drugs & Diagnostic Technologies Market For Histone Modification, By Region, 2024-2034 ($ Billion)
  26. Epigenetics Drugs & Diagnostic Technologies Market For RNA Modification, By Region, 2024-2034 ($ Billion)
  27. Epigenetics Drugs & Diagnostic Technologies Market For Others, By Region, 2024-2034 ($ Billion)
  28. Epigenetics Drugs & Diagnostic Technologies Market Segmentation, By Application
  29. Epigenetics Drugs & Diagnostic Technologies Market For Oncology, By Region, 2024-2034 ($ Billion)
  30. Epigenetics Drugs & Diagnostic Technologies Market For Non-Oncology, By Region, 2024-2034 ($ Billion)
  31. Thermo Fisher Scientific Inc.: Net Sales, 2024-2034 ($ Billion)
  32. Thermo Fisher Scientific Inc.: Revenue Share, By Segment, 2024 (%)
  33. Thermo Fisher Scientific Inc.: Revenue Share, By Region, 2024 (%)
  34. Eisai Co., Ltd.: Net Sales, 2024-2034 ($ Billion)
  35. Eisai Co., Ltd.: Revenue Share, By Segment, 2024 (%)
  36. Eisai Co., Ltd.: Revenue Share, By Region, 2024 (%)
  37. Roche Diagnostics: Net Sales, 2024-2034 ($ Billion)
  38. Roche Diagnostics: Revenue Share, By Segment, 2024 (%)
  39. Roche Diagnostics: Revenue Share, By Region, 2024 (%)
  40. Illumina, Inc.: Net Sales, 2024-2034 ($ Billion)
  41. Illumina, Inc.: Revenue Share, By Segment, 2024 (%)
  42. Illumina, Inc.: Revenue Share, By Region, 2024 (%)
  43. Cantata Bio: Net Sales, 2024-2034 ($ Billion)
  44. Cantata Bio: Revenue Share, By Segment, 2024 (%)
  45. Cantata Bio: Revenue Share, By Region, 2024 (%)
  46. Novartis AG: Net Sales, 2024-2034 ($ Billion)
  47. Novartis AG: Revenue Share, By Segment, 2024 (%)
  48. Novartis AG: Revenue Share, By Region, 2024 (%)
  49. ELEMENT BIOSCIENCES: Net Sales, 2024-2034 ($ Billion)
  50. ELEMENT BIOSCIENCES: Revenue Share, By Segment, 2024 (%)
  51. ELEMENT BIOSCIENCES: Revenue Share, By Region, 2024 (%)
  52. Active Motif Inc.: Net Sales, 2024-2034 ($ Billion)
  53. Active Motif Inc.: Revenue Share, By Segment, 2024 (%)
  54. Active Motif Inc.: Revenue Share, By Region, 2024 (%)
  55. Qiagen.: Net Sales, 2024-2034 ($ Billion)
  56. Qiagen.: Revenue Share, By Segment, 2024 (%)
  57. Qiagen.: Revenue Share, By Region, 2024 (%)
  58. Agilent Technologies: Net Sales, 2024-2034 ($ Billion)
  59. Agilent Technologies: Revenue Share, By Segment, 2024 (%)
  60. Agilent Technologies: Revenue Share, By Region, 2024 (%)
  61. Merck KGaA: Net Sales, 2024-2034 ($ Billion)
  62. Merck KGaA: Revenue Share, By Segment, 2024 (%)
  63. Merck KGaA: Revenue Share, By Region, 2024 (%)
  64. Abcam Limited.: Net Sales, 2024-2034 ($ Billion)
  65. Abcam Limited.: Revenue Share, By Segment, 2024 (%)
  66. Abcam Limited.: Revenue Share, By Region, 2024 (%)
  67. Hoffmann-La Roche Ltd.: Net Sales, 2024-2034 ($ Billion)
  68. Hoffmann-La Roche Ltd.: Revenue Share, By Segment, 2024 (%)
  69. Hoffmann-La Roche Ltd.: Revenue Share, By Region, 2024 (%)
  70. Zymo Research Corporation: Net Sales, 2024-2034 ($ Billion)
  71. Zymo Research Corporation: Revenue Share, By Segment, 2024 (%)
  72. Zymo Research Corporation: Revenue Share, By Region, 2024 (%)
  73. Others: Net Sales, 2024-2034 ($ Billion)
  74. Others: Revenue Share, By Segment, 2024 (%)
  75. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:120
Pages:240
Countries covered:20
Companies covered::18
Forecast CAGR:CAGR of 14.34%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies